SCHEMBL5524401

SCHEMBL5524401

NCC(=O)OC(=O)[C@@H](N)CCC(N)=O.[MgH2]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.48
BLM P54132 1/20 0.48
PMP22 Q01453 1/20 0.48
KMT2A Q03164 1/20 0.48
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
GRM8 O00222 1/20 0.32
GRM6 O15303 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GSR P00390 1/20 0.32
CYP1A2 P05177 1/20 0.32
GRIK1 P39086 1/20 0.32
GRM5 P41594 1/20 0.32
GRIA1 P42261 1/20 0.32
GRIA2 P42262 1/20 0.32
GRIA3 P42263 1/20 0.32
SLC1A3 P43003 1/20 0.32
SLC1A2 P43004 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL869883 0.98 ALOX15 (0.50) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL1685063 0.85 SLC1A1 (0.34) ALOX15BLMPMP22KMT2AGRM8
SCHEMBL28571398 0.85 ALOX15 (0.52) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL352342 0.85 ALOX15 (0.52) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL28313344 0.84 ALOX15 (0.60) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL711607 0.84 ALOX15 (0.60) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL6673186 0.83 GRM8 (0.52) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL9452863 0.81 ALOX15 (0.48) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL7176759 0.80 ALOX15 (0.56) ALOX15BLMPMP22KMT2ADPP4
Potassium Ion SCHEMBL28353514 0.80 CA1 (0.36) ALOX15BLMPMP22KMT2AGRM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11534458-B2 Phosphorus-sparing nutritional composition ALBION LABORATORIES, INC. (US) 2022-12-27 US claimed
US-20210137975-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2021-05-13 US claimed
US-10912796-B2 Phosphorus-sparing nutritional composition ALBION LABORATORIES, INC. (US) 2021-02-09 US claimed
US-20180280430-A1 COMPOSITION FOR IMPROVED PERFORMANCE BALCHEM CORPORATION 2018-10-04 US claimed
EP-3355989-A1 COMPOSITION FOR IMPROVED PERFORMANCE Balchem Corporation (US) 2018-08-08 EP claimed
US-20160015746-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2016-01-21 US claimed
EP-2967117-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION AMIP, LLC (US) 2016-01-20 EP claimed
WO-2014159886-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION AMIP, LLC (US) 2014-10-02 WO claimed
US-8840937-B2 Composition and method for recovery from mild traumatic brain injury FORD JR WALTER JOE (US) 2014-09-23 US claimed
US-20130224169-A1 COMPOSITION AND METHOD FOR RECOVERY FROM MILD TRAUMATIC BRAIN INJURY FORD JR WALTER JOE (US) 2013-08-29 US claimed
US-11534458-B2 Phosphorus-sparing nutritional composition ALBION LABORATORIES, INC. (US) 2022-12-27 US disclosed
US-20220233476-A1 IRON SUPPLEMENT JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2022-07-28 US disclosed
US-20220160830-A1 COMPOSITIONS COMPRISING CHOLINE JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2022-05-26 US disclosed
US-11331287-B2 Iron supplement BALCHEM CORPORATION (US) 2022-05-17 US disclosed
US-11278591-B2 Compositions comprising choline BALCHEM CORPORATION (US) 2022-03-22 US disclosed
WO-2014159886-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION AMIP, LLC (US) 2014-10-02 WO disclosed
US-8840937-B2 Composition and method for recovery from mild traumatic brain injury FORD JR WALTER JOE (US) 2014-09-23 US disclosed
WO-2014008341-A2 COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM NUTRAMAX LABORATORIES, INC. (US) 2014-01-09 WO disclosed
US-20130224169-A1 COMPOSITION AND METHOD FOR RECOVERY FROM MILD TRAUMATIC BRAIN INJURY FORD JR WALTER JOE (US) 2013-08-29 US disclosed
US-20070196496-A1 Delivery systems for functional ingredients FARBER MICHAEL 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11534458-B2 Phosphorus-sparing nutritional composition PHPT1, PPA1, PTH1R ALOX15 1295/4885BLM 4550/4885PMP22 2186/4885
US-20210137975-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION PHPT1, PPA1, PTH1R ALOX15 1295/4885BLM 4550/4885PMP22 2186/4885
US-20160015746-A1 PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION PHPT1, PPA1, PTH1R ALOX15 1295/4885BLM 4550/4885PMP22 2186/4885
US-10912796-B2 Phosphorus-sparing nutritional composition PHPT1, PPA1, PTH1R ALOX15 1295/4885BLM 4550/4885PMP22 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.